Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
Fusarium infections in critically ill patients.

Seminars in respiratory and critical care medicine

Lionakis MS, Kontoyiannis DP.
PMID: 16088459
Semin Respir Crit Care Med. 2004 Apr;25(2):159-69. doi: 10.1055/s-2004-824900.

Invasive mold infections (IMIs) are significant causes of infectious mortality in immunocompromised patients, such as those with hematologic malignancies and allogeneic bone marrow transplant recipients. Of the IMIs, invasive aspergillosis is by far the most common. Nevertheless, over the...

Cite
Lionakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med. 2004;25(2):159-69doi: 10.1055/s-2004-824900.
Lionakis, M. S., & Kontoyiannis, D. P. (2004). Fusarium infections in critically ill patients. Seminars in respiratory and critical care medicine, 25(2), 159-69. https://doi.org/10.1055/s-2004-824900
Lionakis, Michail S, and Kontoyiannis, Dimitrios P. "Fusarium infections in critically ill patients." Seminars in respiratory and critical care medicine vol. 25,2 (2004): 159-69. doi: https://doi.org/10.1055/s-2004-824900
Lionakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med. 2004 Apr;25(2):159-69. doi: 10.1055/s-2004-824900. PMID: 16088459.
Copy Download .nbib Format: NLM
Mucormycosis of the Central Nervous System.

Journal of fungi (Basel, Switzerland)

Chikley A, Ben-Ami R, Kontoyiannis DP.
PMID: 31288475
J Fungi (Basel). 2019 Jul 08;5(3). doi: 10.3390/jof5030059.

Mucormycosis involves the central nervous system by direct extension from infected paranasal sinuses or hematogenous dissemination from the lungs. Incidence rates of this rare disease seem to be rising, with a shift from the rhino-orbital-cerebral syndrome typical of patients...

Cite
Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the Central Nervous System. J Fungi (Basel). 2019;5(3)doi: 10.3390/jof5030059.
Chikley, A., Ben-Ami, R., & Kontoyiannis, D. P. (2019). Mucormycosis of the Central Nervous System. Journal of fungi (Basel, Switzerland), 5(3), . https://doi.org/10.3390/jof5030059
Chikley, Amanda, et al. "Mucormycosis of the Central Nervous System." Journal of fungi (Basel, Switzerland) vol. 5,3 (2019). doi: https://doi.org/10.3390/jof5030059
Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the Central Nervous System. J Fungi (Basel). 2019 Jul 08;5(3). doi: 10.3390/jof5030059. PMID: 31288475; PMCID: PMC6787740.
Copy Download .nbib Format: NLM
A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis.

Open forum infectious diseases

Kontoyiannis DP.
PMID: 27942540
Open Forum Infect Dis. 2016 Dec 08;3(4):ofw209. doi: 10.1093/ofid/ofw209. eCollection 2016 Oct.

No abstract available.

Cite
Kontoyiannis DP. A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis. Open Forum Infect Dis. 2016;3(4):ofw209doi: 10.1093/ofid/ofw209.
Kontoyiannis, D. P. (2016). A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis. Open forum infectious diseases, 3(4), ofw209. https://doi.org/10.1093/ofid/ofw209
Kontoyiannis, Dimitrios P. "A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis." Open forum infectious diseases vol. 3,4 (2016): ofw209. doi: https://doi.org/10.1093/ofid/ofw209
Kontoyiannis DP. A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis. Open Forum Infect Dis. 2016 Dec 08;3(4):ofw209. doi: 10.1093/ofid/ofw209. eCollection 2016 Oct. PMID: 27942540; PMCID: PMC5144653.
Copy Download .nbib Format: NLM
Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.

Open forum infectious diseases

Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Miller AO, Petraitiene R, Lortholary O, Walsh TJ.
PMID: 26858961
Open Forum Infect Dis. 2015 Dec 23;3(1):ofv207. doi: 10.1093/ofid/ofv207. eCollection 2016 Jan.

Background.  Candida arthritis is a debilitating form of deeply invasive candidiasis. However, its epidemiology, clinical manifestations, management, and outcome are not well understood. Methods.  Cases of Candida arthritis were reviewed from 1967 through 2014. Variables included Candida spp in...

Cite
Gamaletsou MN, Rammaert B, Bueno MA, et al. Candida Arthritis: Analysis of 112 Pediatric and Adult Cases. Open Forum Infect Dis. 2015;3(1):ofv207doi: 10.1093/ofid/ofv207.
Gamaletsou, M. N., Rammaert, B., Bueno, M. A., Sipsas, N. V., Moriyama, B., Kontoyiannis, D. P., Roilides, E., Zeller, V., Taj-Aldeen, S. J., Miller, A. O., Petraitiene, R., Lortholary, O., & Walsh, T. J. (2016). Candida Arthritis: Analysis of 112 Pediatric and Adult Cases. Open forum infectious diseases, 3(1), ofv207. https://doi.org/10.1093/ofid/ofv207
Gamaletsou, Maria N, et al. "Candida Arthritis: Analysis of 112 Pediatric and Adult Cases." Open forum infectious diseases vol. 3,1 (2016): ofv207. doi: https://doi.org/10.1093/ofid/ofv207
Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Miller AO, Petraitiene R, Lortholary O, Walsh TJ. Candida Arthritis: Analysis of 112 Pediatric and Adult Cases. Open Forum Infect Dis. 2015 Dec 23;3(1):ofv207. doi: 10.1093/ofid/ofv207. eCollection 2016 Jan. PMID: 26858961; PMCID: PMC4742637.
Copy Download .nbib Format: NLM
Reply to Day et al.

The Journal of infectious diseases

Johnson MD, Lewis RE, Dodds Ashley ES, Perfect JR, Kontoyiannis DP.
PMID: 33822103
J Infect Dis. 2021 Nov 16;224(9):1627-1628. doi: 10.1093/infdis/jiab183.

No abstract available.

Cite
Johnson MD, Lewis RE, Dodds Ashley ES, et al. Reply to Day et al. J Infect Dis. 2021;224(9):1627-1628doi: 10.1093/infdis/jiab183.
Johnson, M. D., Lewis, R. E., Dodds Ashley, E. S., Perfect, J. R., & Kontoyiannis, D. P. (2021). Reply to Day et al. The Journal of infectious diseases, 224(9), 1627-1628. https://doi.org/10.1093/infdis/jiab183
Johnson, Melissa D, et al. "Reply to Day et al." The Journal of infectious diseases vol. 224,9 (2021): 1627-1628. doi: https://doi.org/10.1093/infdis/jiab183
Johnson MD, Lewis RE, Dodds Ashley ES, Perfect JR, Kontoyiannis DP. Reply to Day et al. J Infect Dis. 2021 Nov 16;224(9):1627-1628. doi: 10.1093/infdis/jiab183. PMID: 33822103; PMCID: PMC8599836.
Copy Download .nbib Format: NLM
Aspergillus terreus Species Complex.

Clinical microbiology reviews

Lass-Flörl C, Dietl AM, Kontoyiannis DP, Brock M.
PMID: 34190571
Clin Microbiol Rev. 2021 Dec 15;34(4):e0031120. doi: 10.1128/CMR.00311-20. Epub 2021 Jun 30.

Infections due to

Cite
Lass-Flörl C, Dietl AM, Kontoyiannis DP, et al. Aspergillus terreus Species Complex. Clin Microbiol Rev. 2021;34(4):e0031120doi: 10.1128/CMR.00311-20.
Lass-Flörl, C., Dietl, A. M., Kontoyiannis, D. P., & Brock, M. (2021). Aspergillus terreus Species Complex. Clinical microbiology reviews, 34(4), e0031120. https://doi.org/10.1128/CMR.00311-20
Lass-Flörl, Cornelia, et al. "Aspergillus terreus Species Complex." Clinical microbiology reviews vol. 34,4 (2021): e0031120. doi: https://doi.org/10.1128/CMR.00311-20
Lass-Flörl C, Dietl AM, Kontoyiannis DP, Brock M. Aspergillus terreus Species Complex. Clin Microbiol Rev. 2021 Dec 15;34(4):e0031120. doi: 10.1128/CMR.00311-20. Epub 2021 Jun 30. PMID: 34190571; PMCID: PMC8404697.
Copy Download .nbib Format: NLM
Aspergillus terreus Species Complex.

Clinical microbiology reviews

Lass-Flörl C, Dietl AM, Kontoyiannis DP, Brock M.
PMID: 34190571
Clin Microbiol Rev. 2021 Jun 30;e0031120. doi: 10.1128/CMR.00311-20. Epub 2021 Jun 30.

Infections due to

Cite
Lass-Flörl C, Dietl AM, Kontoyiannis DP, et al. Aspergillus terreus Species Complex. Clin Microbiol Rev. 2021;e0031120doi: 10.1128/CMR.00311-20.
Lass-Flörl, C., Dietl, A. M., Kontoyiannis, D. P., & Brock, M. (2021). Aspergillus terreus Species Complex. Clinical microbiology reviews, e0031120. https://doi.org/10.1128/CMR.00311-20
Lass-Flörl, Cornelia, et al. "Aspergillus terreus Species Complex." Clinical microbiology reviews vol. (2021): e0031120. doi: https://doi.org/10.1128/CMR.00311-20
Lass-Flörl C, Dietl AM, Kontoyiannis DP, Brock M. Aspergillus terreus Species Complex. Clin Microbiol Rev. 2021 Jun 30;e0031120. doi: 10.1128/CMR.00311-20. Epub 2021 Jun 30. PMID: 34190571; PMCID: PMC8404697.
Copy Download .nbib Format: NLM
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.

Mycoses

Thompson GR, Garcia-Diaz J, Miceli MH, Nguyen MH, Ostrosky-Zeichner L, Young JH, Fisher CE, Clark NM, Greenberg RN, Spec A, Kovanda L, Croos-Dabrera R, Kontoyiannis DP.
PMID: 34888961
Mycoses. 2021 Dec 09; doi: 10.1111/myc.13412. Epub 2021 Dec 09.

BACKGROUND: Isavuconazole, administered as isavuconazonium sulfate (ISAVUSULF), is a broad-spectrum triazole agent for the treatment of invasive fungal disease. In phase 3 studies, ISAVUSULF showed comparable efficacy to voriconazole and amphotericin B for the treatment of invasive aspergillosis (IA)...

Cite
Thompson GR, Garcia-Diaz J, Miceli MH, et al. Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study. Mycoses. 2021;doi: 10.1111/myc.13412.
Thompson, G. R., Garcia-Diaz, J., Miceli, M. H., Nguyen, M. H., Ostrosky-Zeichner, L., Young, J. H., Fisher, C. E., Clark, N. M., Greenberg, R. N., Spec, A., Kovanda, L., Croos-Dabrera, R., & Kontoyiannis, D. P. (2021). Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study. Mycoses, . https://doi.org/10.1111/myc.13412
Thompson, George R, et al. "Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study." Mycoses vol. (2021). doi: https://doi.org/10.1111/myc.13412
Thompson GR, Garcia-Diaz J, Miceli MH, Nguyen MH, Ostrosky-Zeichner L, Young JH, Fisher CE, Clark NM, Greenberg RN, Spec A, Kovanda L, Croos-Dabrera R, Kontoyiannis DP. Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study. Mycoses. 2021 Dec 09; doi: 10.1111/myc.13412. Epub 2021 Dec 09. PMID: 34888961.
Copy Download .nbib Format: NLM
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy.

Antimicrobial agents and chemotherapy

DiPippo AJ, McDaneld PM, Tverdek FP, Kontoyiannis DP.
PMID: 34570643
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0123021. doi: 10.1128/AAC.01230-21. Epub 2021 Sep 27.

Posaconazole (POS) appears to have dose-proportional pharmacokinetics; however, there is a paucity of real-life data. We retrospectively evaluated 67 patients with hematologic cancer who had POS dose increases from 300 mg/day to either 400 mg/day (

Cite
DiPippo AJ, McDaneld PM, Tverdek FP, et al. Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy. Antimicrob Agents Chemother. 2021;65(12):e0123021doi: 10.1128/AAC.01230-21.
DiPippo, A. J., McDaneld, P. M., Tverdek, F. P., & Kontoyiannis, D. P. (2021). Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy. Antimicrobial agents and chemotherapy, 65(12), e0123021. https://doi.org/10.1128/AAC.01230-21
DiPippo, Adam J, et al. "Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy." Antimicrobial agents and chemotherapy vol. 65,12 (2021): e0123021. doi: https://doi.org/10.1128/AAC.01230-21
DiPippo AJ, McDaneld PM, Tverdek FP, Kontoyiannis DP. Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0123021. doi: 10.1128/AAC.01230-21. Epub 2021 Sep 27. PMID: 34570643; PMCID: PMC8597744.
Copy Download .nbib Format: NLM
Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study.

Open forum infectious diseases

Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC.
PMID: 31065565
Open Forum Infect Dis. 2019 Apr 04;6(5):ofz173. doi: 10.1093/ofid/ofz173. eCollection 2019 May.

BACKGROUND: Accumulating evidence suggests that the intestinal microbiome may dramatically affect the outcomes of hematopoietic stem cell transplant (HSCT) recipients. Providing 16S ribosomal RNA based microbiome characterization in a clinically actionable time frame is currently problematic. Thus, determination of...

Cite
Galloway-Peña JR, Peterson CB, Malik F, et al. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis. 2019;6(5):ofz173doi: 10.1093/ofid/ofz173.
Galloway-Peña, J. R., Peterson, C. B., Malik, F., Sahasrabhojane, P. V., Shah, D. P., Brumlow, C. E., Carlin, L. G., Chemaly, R. F., Im, J. S., Rondon, G., Felix, E., Veillon, L., Lorenzi, P. L., Alousi, A. M., Jenq, R. R., Kontoyiannis, D. P., Shpall, E. J., Shelburne, S. A., & Okhuysen, P. C. (2019). Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open forum infectious diseases, 6(5), ofz173. https://doi.org/10.1093/ofid/ofz173
Galloway-Peña, Jessica R, et al. "Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study." Open forum infectious diseases vol. 6,5 (2019): ofz173. doi: https://doi.org/10.1093/ofid/ofz173
Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis. 2019 Apr 04;6(5):ofz173. doi: 10.1093/ofid/ofz173. eCollection 2019 May. PMID: 31065565; PMCID: PMC6499899.
Copy Download .nbib Format: NLM
Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma.

Journal of fungi (Basel, Switzerland)

Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DP.
PMID: 31277364
J Fungi (Basel). 2019 Jul 04;5(3). doi: 10.3390/jof5030057.

Necrotizing mucormycosis is a devastating complication of wounds incurred in the setting of military (combat) injuries, natural disasters, burns, or other civilian trauma.

Cite
Walsh TJ, Hospenthal DR, Petraitis V, et al. Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma. J Fungi (Basel). 2019;5(3)doi: 10.3390/jof5030057.
Walsh, T. J., Hospenthal, D. R., Petraitis, V., & Kontoyiannis, D. P. (2019). Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma. Journal of fungi (Basel, Switzerland), 5(3), . https://doi.org/10.3390/jof5030057
Walsh, Thomas J, et al. "Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma." Journal of fungi (Basel, Switzerland) vol. 5,3 (2019). doi: https://doi.org/10.3390/jof5030057
Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DP. Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma. J Fungi (Basel). 2019 Jul 04;5(3). doi: 10.3390/jof5030057. PMID: 31277364; PMCID: PMC6787580.
Copy Download .nbib Format: NLM
First report of kerion (tinea capitis) caused by combined .

Medical mycology case reports

Yang X, Shi X, Chen W, Zhou Y, Lionakis MS, Kontoyiannis DP, Liu W.
PMID: 32477858
Med Mycol Case Rep. 2020 May 19;29:5-7. doi: 10.1016/j.mmcr.2020.05.002. eCollection 2020 Sep.

A 5-year-old boy was presented with large ulcer accompanied by surrounding follicular pustules on the left parietal scalp. Dermoscopy showed "comma" and dystrophic broken hairs. Fungal culture showed mixed growth of two types of colonies.

Cite
Yang X, Shi X, Chen W, et al. First report of kerion (tinea capitis) caused by combined . Med Mycol Case Rep. 2020;29:5-7doi: 10.1016/j.mmcr.2020.05.002.
Yang, X., Shi, X., Chen, W., Zhou, Y., Lionakis, M. S., Kontoyiannis, D. P., & Liu, W. (2020). First report of kerion (tinea capitis) caused by combined . Medical mycology case reports, 295-7. https://doi.org/10.1016/j.mmcr.2020.05.002
Yang, Xinyu, et al. "First report of kerion (tinea capitis) caused by combined ." Medical mycology case reports vol. 29 (2020): 5-7. doi: https://doi.org/10.1016/j.mmcr.2020.05.002
Yang X, Shi X, Chen W, Zhou Y, Lionakis MS, Kontoyiannis DP, Liu W. First report of kerion (tinea capitis) caused by combined . Med Mycol Case Rep. 2020 May 19;29:5-7. doi: 10.1016/j.mmcr.2020.05.002. eCollection 2020 Sep. PMID: 32477858; PMCID: PMC7251309.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries